Skip to Content

Terumo Group

News

Showing 1 to 9 of 53

Apr 24

Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned

Apr 24, 2023
Mar 20

Prospective, Multi-Center, Single-Arm Study Demonstrates Effectiveness of Terumo Medical Corporation’s Cross-Seal™ Suture-Mediated Vascular Closure Device (VCD) System

Mar 20, 2023
Mar 13

Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures

Mar 13, 2023
Mar 2

Terumo to Further Drive DE&I by Establishing Focus Areas to Commit Globally

Mar 02, 2023
Jan 18

First Patient Treated and Enrolled in Terumo Medical Corporation’s Osprey Iliac IDE Clinical Trial

Jan 18, 2023
Nov 1

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

Nov 01, 2022
Sep 17

Terumo Announces Study Results Underscoring Safety and Efficacy of Radial to Peripheral (R2P) Interventions in Treatment of Complex Lower Extremity Peripheral Artery Disease (PAD)

Sep 17, 2022
Jul 8

Terumo Unveils “Terumo’s Purpose” to Enhance Joint Value Creation with Diverse Stakeholders

Jul 08, 2022
Mar 31

Terumo Launches New ‘Terumo Medical Care Solutions’ Brand

Mar 31, 2022

Showing 1 to 9 of 53